Faecal calprotectin: a biomarker of gastrointestinal disease in systemic sclerosis

EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)

(2009) O Kowal-Bielecka et al.   ANNALS OF THE RHEUMATIC DISEASES

Reliability and validity of the university of california, los angeles scleroderma clinical trial consortium gastrointestinal tract instrument

(2009) Dinesh Khanna et al.   ARTHRITIS AND RHEUMATISM

The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

(2009) Jan M. Ehrchen et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Gastrointestinal complications: the most frequent internal complications of systemic sclerosis

(2009) A. Forbes et al.   RHEUMATOLOGY

Classification of anemia for gastroenterologists

(2009) Jose Antonio Moreno Chulilla et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis

(2008) H B. Hammer et al.   ANNALS OF THE RHEUMATIC DISEASES

Endothelial/lymphocyte activation leads to prominent CD4+ T cell infiltration in the gastric mucosa of patients with systemic sclerosis

(2008) Mirko Manetti et al.   ARTHRITIS AND RHEUMATISM

Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease

(2008) J.P. Gisbert et al.   DIGESTIVE AND LIVER DISEASE

Fecal Calprotectin Concentrations in Patients with Small Intestinal Bacterial Overgrowth

(2008) Massimo Montalto et al.   DIGESTIVE DISEASES